Rep. Vindman Introduces MISSION Rx Act to Lower Drug Costs for Veterans and Military Families
The MISSION Rx Act is currently in the early stages of the legislative process. It has been sent to the House Committees on Veterans' Affairs and Armed Services for review. The bill is actively moving as it waits for these committees to consider its provisions.
While lowering drug costs is a popular issue, the bill currently lacks Republican support and faces a difficult path in a divided Congress.
Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
The bill limits the maximum price federal agencies pay for selected drugs to the maximum fair price set by Medicare negotiations. Federal agencies that procure pharmaceuticals for their operations or employees could see reduced drug costs, though the primary beneficiaries are TRICARE and VA populations.
“with respect to each selected drug of the manufacturer procured by a Federal agency, as described in subsection (b), such master agreement shall be subject to the requirements in subsection (j).”
Referred to the Committee on Veterans' Affairs, and in addition to the Committee on Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
No votes, news coverage, or related bills recorded for this bill yet.
Document Type
Congressional Bill
Official Title
MISSION Rx Act
Analysis generated by AI. Always verify with official sources.